Hyperliquid News Today: Abraxas Capital's $760M Short Position Points to an Uncertain Path Ahead for HYPE
- Hyperliquid's HYPE token faces potential 50% price drop due to bearish indicators like growing short positions and competition. - Abraxas Capital's $760M short positions on BTC/ETH and individual traders' aggressive shorting amplify downward pressure risks. - Pump.fun's $1.42M 24-hour revenue surge threatens Hyperliquid's dominance in DeFi derivatives market. - $1B fundraise raises valuation concerns as critics question HYPE's $305M reserves vs 12.6M circulating tokens. - Forrester's AI investment foreca
The cryptocurrency community is rife with talk about a possible 50% drop in the value of Hyperliquid's HYPE token, as a series of negative signals converge. Although the platform recently marked a
 
    One of the main drivers behind the bearish outlook is the surge in short positions taken by institutional investors. On-chain analytics from HyperInsight indicate that two wallets associated with
Retail traders are also taking bearish stances. A notable on-chain trader,
Adding to the worries is the ascent of rival platforms. Defillama data shows that
Even with these challenges, Hyperliquid’s recent $1 billion capital injection is being promoted as a positive sign. The funds are aimed at boosting token reserves and enhancing liquidity, with supporters pointing to the platform’s $317 billion monthly trading volume as evidence of strong demand. However, skeptics argue that this influx of money may have pushed HYPE’s price above its true worth. With $305 million in reserves and 12.6 million tokens in circulation, the token’s real value remains debated, especially as short-term speculation dominates the market mood.
Broader market forces also reinforce the bearish perspective.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin News Update: Major Whale Makes $55M BTC/ETH Move as Crypto ETFs See $62B Inflows Amid Market Rally
- A crypto whale's $55M BTC/ETH long position aligns with $62.34B in BTC ETF inflows, signaling institutional confidence amid mixed technical indicators. - Michael Saylor's Strategy (MSTR) added 397 BTC ($45.6M) to its 641k token portfolio, boosting holdings to $69B as Q3 net income hit $2.8B from unrealized gains. - BTC faces critical $110,163 breakout potential with $115,600-$118,000 resistance, while ETH risks short squeezes below $4,101 amid negative funding rates. - November's historical 42.5% BTC ave

Stellar (XLM) Rises 1.15% Amid Smart Contract Growth and On-Chain Data Indicating Fundamental Change
- Stellar (XLM) rose 1.15% in 24 hours amid 700% smart contract growth and $5.4B RWA volume, signaling potential market realignment. - Protocol 23 upgrade boosted transaction throughput to 5,000/sec, enhancing institutional use cases like remittances and asset tokenization. - Developer activity surged with 200+ new projects and 150% higher daily active addresses, indicating robust ecosystem adoption. - Backtest analysis showed -2.36% 30-day returns after 10% drops, underscoring long-term risks despite shor
DOGE Increases by 1.03% Following the Merger of Brag House and House of Doge, Creating a Major Financial Infrastructure Powerhouse
- Brag House and House of Doge merged on Nov 3, 2025, forming a financial infrastructure firm focused on digital payments, asset management, RWA tokenization, and digital media. - The merger aims to expand Dogecoin's utility via payment rails and tokenized assets, leveraging its $30B market cap and 6.1M holders to build real-world transaction infrastructure. - Despite a 1.03% 24-hour DOGE price rise, the coin fell 46.47% year-to-date, with technical analysis showing no statistically significant edge after
Algo Price Rises 1.37% Following Biotech Trial and Partnership with Hookah Brand
- ALGO rose 1.37% in 24 hours to $0.1628 but fell 51.45% annually amid broader market declines. - Allogene’s trial highlights cema-cel’s potential for lymphoma treatment, while AIR’s Snoop Dogg collaboration expands premium hookah flavors. - Both events reflect innovation in biotech and consumer goods, indirectly influencing investor sentiment through market theme shifts. - A backtest showed 503 ALGO surges with 1.37%+ gains, but 7-day returns averaged +0.06% with only 46% positive outcomes.